← Leaderboards
Robert Hans Ingemar Andtbacka
Vestan, Inc.
$998,298
Attributed
$2,994,893
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–12$1M$750K$500K$250K$0
'10
'11
'12
Funding mix
By agency
NIH$2,994,893 · 1
By mechanism
R42$2,994,893 · 1
Top collaborators
- Charles Buell Grissom3 shared
- James M Mcgreevy3 shared
Most similar at Vestan, Inc.
Same institution · by research overlap
- James M McGreevy$1,302,393
- Charles Buell Grissom$998,298
Others in their field
Top investigators on “Drug Formulations”
- David Heimbrook · Leidos Biomedical Research, Inc.$143,562,560
- Sharon A Nachman · Johns Hopkins University$135,132,510
- Jaap Goudsmit · Janessen Vaccines And Prevention, Bv$70,218,020
- Thomas Macvittie · University Of Maryland Baltimore$64,108,499
- David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health$63,773,218
- Polly Chang · Sri International$60,528,575
Research focus
Drug FormulationsAgreementAm 80Applications GrantsAreaAnaphylaxisBackAnimal DataCanadaCancer InterventionCancer TypeCaringClinical TrialsCollectionColloidsCommunity HospitalsCostDetectionDevicesDirect CostsDoseDropoutDrug ClearanceDrug Kinetics